Cargando…

Theophylline is able to partially revert cachexia in tumour-bearing rats

BACKGROUND AND AIMS: The aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. METHODS: The in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olivan, Mireia, Springer, Jochen, Busquets, Sílvia, Tschirner, Anika, Figueras, Maite, Toledo, Miriam, Fontes-Oliveira, Cibely, Genovese, Maria Inés, Ventura da Silva, Paula, Sette, Angelica, López-Soriano, Francisco J, Anker, Stefan, Argilés, Josep M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495887/ https://www.ncbi.nlm.nih.gov/pubmed/22909172 http://dx.doi.org/10.1186/1743-7075-9-76

Ejemplares similares

Formoterol in the treatment of experimental cancer cachexia: effects on heart function
por: Toledo, Míriam, et al.
Publicado: (2014)

Cachexia: a problem of energetic inefficiency
por: Argilés, Josep M., et al.
Publicado: (2014)

Optimal management of cancer anorexia–cachexia syndrome
por: Argilés, Josep M, et al.
Publicado: (2010)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies
por: Tschirner, Anika, et al.
Publicado: (2012)

Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3
por: Toledo, Míriam, et al.
Publicado: (2014)

Febuxostat improves outcome in a rat model of cancer cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015)

Nonmuscle Tissues Contribution to Cancer Cachexia
por: Argilés, Josep M., et al.
Publicado: (2015)

Therapeutic strategies against cancer cachexia
por: Argilés, Josep M., et al.
Publicado: (2019)

The animal cachexia score (ACASCO)
por: Betancourt, Angelica, et al.
Publicado: (2019)

Influence of cancer cachexia on drug liver metabolism and renal elimination in rats
por: Cvan Trobec, Katja, et al.
Publicado: (2015)

Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model
por: Tzika, A. Aria, et al.
Publicado: (2013)

The cachexia score (CASCO): a new tool for staging cachectic cancer patients
por: Argilés, Josep M., et al.
Publicado: (2011)

MT‐102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia
por: Pötsch, Mareike S., et al.
Publicado: (2020)

Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia
por: CONSTANTINOU, CATERINA, et al.
Publicado: (2011)

The atypical β‐blocker S‐oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model
por: Yuan, Luping, et al.
Publicado: (2022)

Are there any benefits of exercise training in cancer cachexia?
por: Argilés, Josep M., et al.
Publicado: (2012)

Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
por: Springer, Jochen, et al.
Publicado: (2023)

Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise
por: Penna, Fabio, et al.
Publicado: (2011)

A multifactorial anti‐cachectic approach for cancer cachexia in a rat model undergoing chemotherapy
por: Toledo, Míriam, et al.
Publicado: (2015)

Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation
por: Musolino, Vincenzo, et al.
Publicado: (2016)

Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?
por: Toledo, Míriam, et al.
Publicado: (2011)

Lack of Synergy Between β-Agonist Treatment and a Blockage of Sarcoplasmic Calcium Flow in a Rat Cancer Cachexia Model
por: Busquets, Silvia, et al.
Publicado: (2021)

Six1 is down‐regulated in end‐stage human dilated cardiomyopathy independently of Ezh2
por: Tschirner, Anika, et al.
Publicado: (2015)

Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool
por: Argilés, Josep M., et al.
Publicado: (2017)

Open source in cachexia?
por: Stemmler, Britta, et al.
Publicado: (2015)

Cardiac cachexia: hic et nunc
por: Loncar, Goran, et al.
Publicado: (2016)

Theophylline
por: Barnes, Peter J.
Publicado: (2010)

Nutrition in cachexia: from bench to bedside
por: Konishi, Masaaki, et al.
Publicado: (2016)

The 10th year of the Journal of Cachexia, Sarcopenia and Muscle
por: Anker, Markus S., et al.
Publicado: (2020)

Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
por: Anker, Markus S., et al.
Publicado: (2013)

Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Madeddu, Clelia, et al.
Publicado: (2023)

Inflammation in Cachexia
por: Seelaender, M., et al.
Publicado: (2015)

Cardiac cachexia
por: Lena, Alessia, et al.
Publicado: (2019)

Cachexia in heart disease: highlights from the ESC 2010
por: Kung, Thomas, et al.
Publicado: (2011)

Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact
por: Konishi, Masaaki, et al.
Publicado: (2016)

Reproductive toxicology. Theophylline.
Publicado: (1997)

Clinical problems of patients with cachexia due to chronic illness: a congress report
por: Hadzibegovic, Sara, et al.
Publicado: (2020)

Cachexia: a nutritional syndrome?
por: Anker, Stefan D, et al.
Publicado: (2015)

Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats
por: Carbó, N, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_nip7qcpvgph1q46bhghmk7d2lq